Loxapine succinate in the treatment of uncontrollable destructive behavior.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003989:Dibenzoxazepines / Q000009:adverse effects / Q000627:therapeutic use*; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012561:Schizophrenia, Childhood / Q000188:drug therapy*; D012652:Self Mutilation / Q000188:drug therapy
D003989:Dibenzoxazepines